Exact Mass: 349.202

Exact Mass Matches: 349.202

Found 101 metabolites which its exact mass value is equals to given mass value 349.202, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cetiedil

3-Thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1H-azepin-1-yl)ethyl ester, hydrochloride (1:1)

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


Murrayazolinine is found in herbs and spices. Murrayazolinine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree

   

Mahanimbinine

5-{3,5-dimethyl-3H,11H-pyrano[3,2-a]carbazol-3-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


Mahanimbinine is found in herbs and spices. Mahanimbinine is an alkaloid from leaves of Murraya koenigii (curryleaf tree

   

Coutaric acid

4-[(2R)-2-(Aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-YL]-3-[(1-ethylpropyl)amino]benzoic acid

C18H27N3O4 (349.2001)


Coutaric acid is a fecal metabolite from grape juice. It may also be in urine. It is an ester formed from coumaric acid and tartaric acid.

   

(5Z)-(15S)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate

(5Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]hept-5-enoate

C20H29O5 (349.2015)


(5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products. (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products.

   

Murrayamine O

Murrayamine O

C23H27NO2 (349.2042)


   
   
   
   

CHEMBL3431128

CHEMBL3431128

C19H23N7 (349.2015)


   

Mahanimbinine

5-{5,8-dimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaen-5-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


   

SCHEMBL4904241

SCHEMBL4904241

C23H27NO2 (349.2042)


   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0^{2,14}.0^{3,11}.0^{5,10}]icosa-2,5,7,9,11,13-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Coutaric acid

4-[(2R)-2-(aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-yl]-3-[(pentan-3-yl)amino]benzoic acid

C18H27N3O4 (349.2001)


   

L-Alanine, N-(1-carboxyethyl)- (9CI)

L-Alanine, N-(1-carboxyethyl)- (9CI)

C17H32ClNO4 (349.202)


   

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

C23H27NO2 (349.2042)


   

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

C18H27N3O4 (349.2001)


   

azepan-2-one,butane-1,4-diol,hexanedioic acid

azepan-2-one,butane-1,4-diol,hexanedioic acid

C16H31NO7 (349.21)


   

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

C18H27N3O4 (349.2001)


   

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

C15H31NO6Si (349.1921)


   

Trifluralin D14 (di-n-propyl D14)

Trifluralin D14 (di-n-propyl D14)

C13H2D14F3N3O4 (349.1972)


   

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

C18H28BNO5 (349.206)


   

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

C20H24BN3O2 (349.1961)


   

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

C23H27NO2 (349.2042)


   

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

C18H27N3O4 (349.2001)


   
   

MENTHOLGLUCURONIC ACID AMMONIUM SALT

MENTHOLGLUCURONIC ACID AMMONIUM SALT

C16H31NO7 (349.21)


   

Methylamino-phenylalanyl-leucyl-hydroxamic acid

Methylamino-phenylalanyl-leucyl-hydroxamic acid

C18H27N3O4 (349.2001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   
   

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

C18H27N3O4 (349.2001)


   

resolvin E1(1-)

resolvin E1(1-)

C20H29O5- (349.2015)


An icosanoid anion resulting from the removal of a proton from the carboxy group of resolvin E1; major species at pH 7.3.

   

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion arising from deprotonation of the carboxylic acid function of 5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid; major species at pH 7.3.

   

15-dehydro-prostaglandin E2(1-)

15-dehydro-prostaglandin E2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin E2.

   

15-dehydro-prostaglandin I2(1-)

15-dehydro-prostaglandin I2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin I2.

   

15-dehydro-prostaglandin D2(1-)

15-dehydro-prostaglandin D2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin D2.

   

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-18-hydroxy-EPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   
   

prostaglandin D3(1-)

prostaglandin D3(1-)

C20H29O5- (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

15-oxolipoxin A4(1-)

15-oxolipoxin A4(1-)

C20H29O5- (349.2015)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 15-oxolipoxin A4; major species at pH 7.3.

   

20-oxoleukotriene B4(1-)

20-oxoleukotriene B4(1-)

C20H29O5- (349.2015)


A leukotriene anion that is the conjugate base of 20-oxoleukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

C20H29O5- (349.2015)


   

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

C20H29O5- (349.2015)


   

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

C19H28FN3S (349.1988)


   

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

C20H29O5- (349.2015)


   

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

C20H29O5- (349.2015)


   

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

C18H27N3O4 (349.2001)


   
   
   
   
   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   
   
   
   
   

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

C19H23N7 (349.2015)


   

Cetiedil

2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

prostaglandin E3(1-)

prostaglandin E3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin E3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin H3(1-)

prostaglandin H3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin H3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18S)-resolvin E1(1-)

(18S)-resolvin E1(1-)

C20H29O5 (349.2015)


An icosanoid anion that is the conjugate base of (18S)-resolvin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

C23H27NO2 (349.2042)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

lecanindole a

lecanindole a

C23H27NO2 (349.2042)


   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)